Polpharma Pharmaceutical Works - API Manufacturer

POLPHARMA has an outstanding track-record in supplying regulated markets.

Our sales are global on all continents. Over 75% of our API's are sold to external customers. Our sales are realized either through direct business contact with customers or – in the case of certain markets through commission agents. The remaining production of our APIs goes to captive use.

In 2010, 17% of our API's export went to the US market and almost 70% to Europe. The majority of our API sales in the rest of the world were directed to Korea and Japan.

 API sales structure 2010

In 2009 Polpharma API export sales were 40% to the European Union and over 25% to North America.